Zymergen Inc.
ZYDelisted- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001645842
Zymergen Inc. was delisted in 2022; its insiders filed their last Form 4 on Oct 21, 2022; 86 institutions reported holding it in 13F filings for Q3 2022, worth $168.1M in total; ARK Invest was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Zymergen Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Zymergen Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| SB Investment Advisers (UK) Ltd | 10% Owner | 0Indirect | Oct 21, 2022 | 0 |
| Softbank Vision Fund (Aiv M1) L.P. | 10% Owner | 0Indirect | Oct 21, 2022 | 0 |
| SVF Endurance (Cayman) Ltd | 10% Owner | 0Indirect | Oct 21, 2022 | 0 |
| SVF Excalibur (Cayman) Ltd | 10% Owner | 0Indirect | Oct 21, 2022 | 0 |
| Flatley Jay T | Chairman and Acting CEO | 0 | Oct 19, 2022 | 0 |
| Peterson Sandra E | Director | 0 | Oct 19, 2022 | 0 |
| Chu Steven | Director | 0 | Oct 19, 2022 | 0 |
| Gorjanc Christine Marie | Director | 0 | Oct 19, 2022 | 0 |
| Ocko Matthew | Director | 0Indirect | Oct 19, 2022 | 0 |
| Serber Zachariah | Director | 0Indirect | Oct 19, 2022 | 0 |
| Murdoch Travis | Director | 0 | Oct 19, 2022 | 0 |
| Sharma Rohit | Director | – | Oct 19, 2022 | 0 |
| Singh Enakshi | Chief Financial Officer | 0 | Oct 19, 2022 | 0 |
| Kim Mina | Chief Legal Officer | 298,427 | Sep 7, 2022 | 0 |
| Kimball Aaron | Chief Technology Officer | 712,644 | Apr 5, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2022 (view filing) | Oct 3 | 2 days | Singh EnakshiChief Financial Officer | SSale | −3.79K | $2.80 | −$10.6K | −0.8%462.2K after | |
| Sep 7, 2022 (view filing) | Sep 2 | 5 days | Singh EnakshiChief Financial Officer | SSale | −3.93K | $2.21 | −$8.68K | −0.8%466.0K after | |
| Sep 7, 2022 (view filing) | Sep 2 | 5 days | Kim MinaChief Legal Officer | SSale | −3.41K | $2.21 | −$7.54K | −1.1%298.4K after | |
| Sep 7, 2022 (view filing) | Sep 2 | 5 days | Serber ZachariahChief Science Officer | SSale | −3.27K | $2.21 | −$7.22K | −0.1%2.55M after | |
| Sep 1, 2022 (view filing) | Aug 30 | 2 days | Singh EnakshiChief Financial Officer | SSale | −15.4K | $2.27 | −$34.9K | −3.2%470.0K after | |
| Aug 15, 2022 (view filing) | Aug 11 | 4 days | Serber ZachariahChief Science Officer | SSale | −5.43K | $3.91 | −$21.3K | −0.2%2.55M after | |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Serber ZachariahChief Science Officer | SSale | −2.97K | $2.61 | −$7.74K | −0.1%2.56M after | |
| Aug 4, 2022 (view filing) | Aug 2 | 2 days | Kim MinaChief Legal Officer | SSale | −3.09K | $2.61 | −$8.08K | −1.0%301.8K after | |
| Jul 7, 2022 (view filing) | Jul 5 | 2 days | Serber ZachariahChief Science Officer | SSale | −2.80K | $1.32 | −$3.69K | −0.1%2.56M after | |
| Jul 7, 2022 (view filing) | Jul 5 | 2 days | Kim MinaChief Legal Officer | SSale | −2.92K | $1.32 | −$3.86K | −0.9%304.9K after | |
| Jun 6, 2022 (view filing) | Jun 2 | 4 days | Kim MinaChief Legal Officer | SSale | −2.94K | $1.68 | −$4.94K | −0.9%307.9K after | |
| Jun 6, 2022 (view filing) | Jun 2 | 4 days | Serber ZachariahChief Science Officer | SSale | −2.81K | $1.68 | −$4.72K | −0.1%2.57M after | |
| May 4, 2022 (view filing) | May 2 | 2 days | Serber ZachariahChief Science Officer | SSale | −3.08K | $1.79 | −$5.52K | −0.1%2.57M after | |
| May 4, 2022 (view filing) | May 2 | 2 days | Kim MinaChief Legal Officer | SSale | −3.21K | $1.79 | −$5.74K | −1.0%310.8K after | |
| Apr 5, 2022 (view filing) | Apr 1 | 4 days | Kimball AaronChief Technology Officer | SSale | −32.6K | $2.86 | −$93.5K | −4.4%712.6K after | 2 lots |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Kimball AaronChief Technology Officer | SSale | −25.0K | $3.81 | −$95.3K | −3.2%745.3K after | |
| Mar 1, 2022 (view filing) | Feb 25-28 | 4 days | Serber ZachariahChief Science Officer | SSale | −9.45K | $3.92 | −$37.0K | −0.4%2.36M after | 2 lots |
| Feb 24, 2022 (view filing) | Feb 22 | 2 days | Serber ZachariahChief Science Officer | SSale | −1.42K | $3.91 | −$5.57K | −0.1%2.37M after | |
| Feb 16, 2022 (view filing) | Feb 14 | 2 days | Serber ZachariahChief Science Officer | SSale | −5.43K | $4.00 | −$21.7K | −0.2%2.37M after | |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Serber ZachariahChief Science Officer | SSale | −5.43K | $4.33 | −$23.5K | −0.2%2.38M after | |
| Feb 3, 2022 (view filing) | Feb 1 | 2 days | Kimball AaronChief Technology Officer | SSale | −25.0K | $5.06 | −$126.5K | −3.1%770.3K after | |
| Feb 2, 2022 (view filing) | Jan 31 | 2 days | Serber ZachariahChief Science Officer | SSale | −5.43K | $5.03 | −$27.3K | −0.2%2.39M after | |
| Jan 26, 2022 (view filing) | Jan 24 | 2 days | Serber ZachariahChief Science Officer | SSale | −21.7K | $4.76 | −$103.4K | −0.9%2.39M after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Kimball AaronChief Technology Officer | SSale | −50.0K | $5.18 | −$259.0K | −5.9%795.3K after | |
| Nov 19, 2021 (view filing) | Nov 17 | 2 days | Flatley Jay TChairman and Acting CEO | PPurchase | +100.0K | $10.00 | +$1.00M | +223.3%144.8K after |